Romina Weiss > Goodwin > New York, United States > Lawyer Profile
Goodwin Offices
THE NEW YORK TIMES BUILDING
620 EIGHTH AVENUE
NEW YORK NY 10018
NEW YORK
United States
- Firm Profile
- Go to...
Romina Weiss
Position
Partner
Career
Romina Weiss, a partner in Goodwin’s Tax practice and ESG & Impact practice, has broad experience in corporate and partnership tax matters. Ms. Weiss advises public and private U.S. and international companies on tax issues arising from complex business transactions, including mergers and acquisitions, within the private equity and technology industries, among others. She has significant experience in the organization of private equity funds, including buyout, secondary and real estate funds, and advising them on continuing operations, portfolio investments and M&A transactions. She also advises clients on the tax aspects of capital-raising activities, such as IPOs, equity derivatives and debt offerings.
Prior to joining Goodwin, Ms. Weiss was a partner at Gibson Dunn & Crutcher LLP.
Education
JD, 1991, Harvard Law School (cum laude) / BA, 1988, Columbia University (summa cum laude)
Lawyer Rankings
United States > Tax > US taxes: non-contentious
Goodwin advises a wide range of industries, from private equity to tech. With particular strength in the life sciences and real estate sectors, the group advises on REITs, company formations, M&A, joint ventures, public and private securities offerings, and more. The group is led by Neal Sandford in Boston, who holds particular expertise in structuring tax-sensitive commercial transactions, international tax issues, and workouts. Co-chair Kelsey LeMaster in San Francisco advises on fund formations, investment structuring, REITs, and real estate transactions. New York’s Janet Andolina specializes in general corporate, real estate, and international taxation matters. Other key figures within the practice include tax experts Edward Glazer and Howard Cubell in Boston, and Romina Weiss in New York.
Lawyer Rankings
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation